We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Nucleostemin Plays Critical Role in Stem Cell Maintenance

By Biotechdaily staff writers
Posted on 10 Dec 2002
Researchers have found that the protein encoded by the nucleostemin gene is necessary for maintaining the proliferative capacity of embryonic and adult stem cells, and possibly some types of cancer cells. More...
Their findings were published in the December 1, 2002, issue of Genes & Development.

Nucleostemin was originally identified as a protein abundantly expressed in rat central nervous system stem cells that was markedly down-regulated during differentiation, suggesting a possible role in stem cell maintenance. In the current study, researchers from the National Institutes of Health (NIH, Bethesda, MD, USA) found that nucleostemin was expressed in various adult and embryonic stem cell populations, as well as in some human cancer cell lines, and that its expression was consistently turned off during the differentiation of stem cells into more specialized cell types.

First author Dr. RobertTsai explained, "The characterization of nucleostemin suggests that a unique primitive state is shared by both stem cells and cancer cell lines. The identification of common molecules shared by both stem cells and cancer cells may facilitate the discovery of self-renewing populations within a given tumor by evaluating their expression levels. Perhaps, in the future, targeting these cells will achieve a better therapeutic outcome.”



Related Links:
National Institutes of Health

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Prefilled Tubes
Prefilled 5.0ml Tubes
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.